Sanofi bets on mRNA vaccines beyond COVID in $3.2 bln Translate Bio deal
Published
Sanofi (SASY.PA) has agreed to buy U.S. biotech company Translate Bio (TBIO.O) in a $3.2 billion deal, as it bets on next-generation...
Full ArticlePublished
Sanofi (SASY.PA) has agreed to buy U.S. biotech company Translate Bio (TBIO.O) in a $3.2 billion deal, as it bets on next-generation...
Full ArticleFrench pharma group tries to catch up with rivals who used the technology to create Covid vaccines